Get Real Time Here
| Open15.810 | Close15.690 |
| Vol / Avg.111.042K / 644.969K | Mkt Cap483.362M |
| Day Range15.440 - 16.050 | 52 Wk Range7.120 - 24.130 |
UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary
UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.
| Open15.810 | Close15.690 |
| Vol / Avg.111.042K / 644.969K | Mkt Cap483.362M |
| Day Range15.440 - 16.050 | 52 Wk Range7.120 - 24.130 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.140 | -1.030 | 0.1100 | ||||
| REV | 20.120M | 21.139M | 1.019M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 54.00 |
| 2023-08-01 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Raises | 23.00 | 54.00 |
| 2023-07-31 | Goldman Sachs | Paul Choi | Maintains | NeutralNeutral | Raises | 11.00 | 18.00 |
| 2023-06-21 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 23.00 |
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.
Who are UroGen Pharma's (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the target price for UroGen Pharma (URGN) stock?
The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 244.17% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $15.69 last updated September 22, 2023 at 8:00 PM UTC.
Does UroGen Pharma (URGN) pay a dividend?
There is no dividend information for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary
UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.
| Open15.810 | Close15.690 |
| Vol / Avg.111.042K / 644.969K | Mkt Cap483.362M |
| Day Range15.440 - 16.050 | 52 Wk Range7.120 - 24.130 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.140 | -1.030 | 0.1100 | ||||
| REV | 20.120M | 21.139M | 1.019M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 54.00 |
| 2023-08-01 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Raises | 23.00 | 54.00 |
| 2023-07-31 | Goldman Sachs | Paul Choi | Maintains | NeutralNeutral | Raises | 11.00 | 18.00 |
| 2023-06-21 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 23.00 |
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.
Who are UroGen Pharma's (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the target price for UroGen Pharma (URGN) stock?
The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 244.17% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $15.69 last updated September 22, 2023 at 8:00 PM UTC.
Does UroGen Pharma (URGN) pay a dividend?
There is no dividend information for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary
UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.
| Open15.810 | Close15.690 |
| Vol / Avg.111.042K / 644.969K | Mkt Cap483.362M |
| Day Range15.440 - 16.050 | 52 Wk Range7.120 - 24.130 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.140 | -1.030 | 0.1100 | ||||
| REV | 20.120M | 21.139M | 1.019M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 54.00 |
| 2023-08-01 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Raises | 23.00 | 54.00 |
| 2023-07-31 | Goldman Sachs | Paul Choi | Maintains | NeutralNeutral | Raises | 11.00 | 18.00 |
| 2023-06-21 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 23.00 |
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.
Who are UroGen Pharma's (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the target price for UroGen Pharma (URGN) stock?
The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 244.17% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $15.69 last updated September 22, 2023 at 8:00 PM UTC.
Does UroGen Pharma (URGN) pay a dividend?
There is no dividend information for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary
UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.
| Open15.810 | Close15.690 |
| Vol / Avg.111.042K / 644.969K | Mkt Cap483.362M |
| Day Range15.440 - 16.050 | 52 Wk Range7.120 - 24.130 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.140 | -1.030 | 0.1100 | ||||
| REV | 20.120M | 21.139M | 1.019M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 54.00 |
| 2023-08-01 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Raises | 23.00 | 54.00 |
| 2023-07-31 | Goldman Sachs | Paul Choi | Maintains | NeutralNeutral | Raises | 11.00 | 18.00 |
| 2023-06-21 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 23.00 |
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.
Who are UroGen Pharma's (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the target price for UroGen Pharma (URGN) stock?
The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 244.17% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $15.69 last updated September 22, 2023 at 8:00 PM UTC.
Does UroGen Pharma (URGN) pay a dividend?
There is no dividend information for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary
UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.
| Open15.810 | Close15.690 |
| Vol / Avg.111.042K / 644.969K | Mkt Cap483.362M |
| Day Range15.440 - 16.050 | 52 Wk Range7.120 - 24.130 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.140 | -1.030 | 0.1100 | ||||
| REV | 20.120M | 21.139M | 1.019M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 54.00 |
| 2023-08-01 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Raises | 23.00 | 54.00 |
| 2023-07-31 | Goldman Sachs | Paul Choi | Maintains | NeutralNeutral | Raises | 11.00 | 18.00 |
| 2023-06-21 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 23.00 |
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.
Who are UroGen Pharma's (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the target price for UroGen Pharma (URGN) stock?
The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 244.17% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $15.69 last updated September 22, 2023 at 8:00 PM UTC.
Does UroGen Pharma (URGN) pay a dividend?
There is no dividend information for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary
UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.
| Open15.810 | Close15.690 |
| Vol / Avg.111.042K / 644.969K | Mkt Cap483.362M |
| Day Range15.440 - 16.050 | 52 Wk Range7.120 - 24.130 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.140 | -1.030 | 0.1100 | ||||
| REV | 20.120M | 21.139M | 1.019M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 54.00 |
| 2023-08-01 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Raises | 23.00 | 54.00 |
| 2023-07-31 | Goldman Sachs | Paul Choi | Maintains | NeutralNeutral | Raises | 11.00 | 18.00 |
| 2023-06-21 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 23.00 |
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.
Who are UroGen Pharma's (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the target price for UroGen Pharma (URGN) stock?
The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 244.17% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $15.69 last updated September 22, 2023 at 8:00 PM UTC.
Does UroGen Pharma (URGN) pay a dividend?
There is no dividend information for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary
UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.
| Open15.810 | Close15.690 |
| Vol / Avg.111.042K / 644.969K | Mkt Cap483.362M |
| Day Range15.440 - 16.050 | 52 Wk Range7.120 - 24.130 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.140 | -1.030 | 0.1100 | ||||
| REV | 20.120M | 21.139M | 1.019M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 54.00 |
| 2023-08-01 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Raises | 23.00 | 54.00 |
| 2023-07-31 | Goldman Sachs | Paul Choi | Maintains | NeutralNeutral | Raises | 11.00 | 18.00 |
| 2023-06-21 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 23.00 |
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.
Who are UroGen Pharma's (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the target price for UroGen Pharma (URGN) stock?
The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 244.17% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $15.69 last updated September 22, 2023 at 8:00 PM UTC.
Does UroGen Pharma (URGN) pay a dividend?
There is no dividend information for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary
UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.
| Open15.810 | Close15.690 |
| Vol / Avg.111.042K / 644.969K | Mkt Cap483.362M |
| Day Range15.440 - 16.050 | 52 Wk Range7.120 - 24.130 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.140 | -1.030 | 0.1100 | ||||
| REV | 20.120M | 21.139M | 1.019M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 54.00 |
| 2023-08-01 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Raises | 23.00 | 54.00 |
| 2023-07-31 | Goldman Sachs | Paul Choi | Maintains | NeutralNeutral | Raises | 11.00 | 18.00 |
| 2023-06-21 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 23.00 |
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.
Who are UroGen Pharma's (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the target price for UroGen Pharma (URGN) stock?
The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 244.17% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $15.69 last updated September 22, 2023 at 8:00 PM UTC.
Does UroGen Pharma (URGN) pay a dividend?
There is no dividend information for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
UroGen Pharma Stock (NASDAQ:URGN), Quotes and News Summary
UroGen Pharma Stock (NASDAQ: URGN) stock price, news, charts, stock research, profile.
| Open15.810 | Close15.690 |
| Vol / Avg.111.042K / 644.969K | Mkt Cap483.362M |
| Day Range15.440 - 16.050 | 52 Wk Range7.120 - 24.130 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.140 | -1.030 | 0.1100 | ||||
| REV | 20.120M | 21.139M | 1.019M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 54.00 |
| 2023-08-01 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Raises | 23.00 | 54.00 |
| 2023-07-31 | Goldman Sachs | Paul Choi | Maintains | NeutralNeutral | Raises | 11.00 | 18.00 |
| 2023-06-21 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 23.00 |
How do I buy UroGen Pharma (URGN) stock?
You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.
Who are UroGen Pharma's (URGN) competitors?
There are no as such competitors for UroGen Pharma.
What is the target price for UroGen Pharma (URGN) stock?
The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 244.17% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for UroGen Pharma (URGN)?
The stock price for UroGen Pharma (NASDAQ: URGN) is $15.69 last updated September 22, 2023 at 8:00 PM UTC.
Does UroGen Pharma (URGN) pay a dividend?
There is no dividend information for UroGen Pharma.
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
UroGen Pharma’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is UroGen Pharma (URGN) going to split?
There is no upcoming split for UroGen Pharma.
What sector and industry does UroGen Pharma (URGN) operate in?
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.